1887

Abstract

Four monoclonal antibodies (mAbs) recognizing distinct antigenic sites on the HA2 glycopolypeptide of influenza virus A/Dunedin/4/73 (H3N2) have been tested for protection. When applied intravenously before infection, three of them increased the survival of BALB/c mice infected with 1 LD homologous virus. The protection resulted simultaneously in 2 days earlier clearance of virus from the lungs. These three antibodies inhibited the fusion activity of virus in previous experiments. One of them, specific to N-terminal aa 1–38 of the HA2 glycopolypeptide, was also tested for protection against the heterologous virus A/Mississippi/1/85 (H3N2). Protection similar to that against the homologous virus was observed. The fourth mAb, without fusion-inhibition activity, did not protect mice. It is concluded that antibodies specific to the antigenically conserved HA2 glycopolypeptide that exhibit fusion-inhibition activity can contribute to the protection of infected mice and mediate more effective recovery from infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82563-0
2007-03-01
2019-11-16
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/3/951.html?itemId=/content/journal/jgv/10.1099/vir.0.82563-0&mimeType=html&fmt=ahah

References

  1. Becht, H., Huang, R. T. C., Fleischer, B., Boschek, C. B. & Rott, R. ( 1984; ). Immunogenic properties of the small chain HA2 of the haemagglutinin of influenza viruses. J Gen Virol 65, 173–183.[CrossRef]
    [Google Scholar]
  2. Bystrická, M., Petríková, M., Zat'ovičová, M., Soláriková, L., Kostolanský, F., Mucha, V. & Russ, G. ( 1997; ). Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection. Acta Virol 41, 5–12.
    [Google Scholar]
  3. Cox, N. J., Tamblyn, S. E. & Tam, T. ( 2003; ). Influenza pandemic planning. Vaccine 21, 1801–1803.[CrossRef]
    [Google Scholar]
  4. Ey, P. L., Prowse, S. J. & Jenkin, C. R. ( 1978; ). Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using Protein A-Sepharose. Immunochemistry 15, 429–436.[CrossRef]
    [Google Scholar]
  5. Fislová, T., Sládková, T., Gocník, M., Mucha, V., Varečková, E. & Kostolanský, F. ( 2005; ). Differences in antibody responses of mice to intranasal or intraperitoneal immunization with influenza A virus and vaccination with subunit influenza vaccine. Acta Virol 49, 243–250.
    [Google Scholar]
  6. Gerhard, W. ( 2001; ). The role of the antibody response in influenza virus infection. Curr Top Microbiol Immunol 260, 171–190.
    [Google Scholar]
  7. Gould, K. G., Scotney, H., Townsend, A. R., Bastin, J. & Brownlee, G. G. ( 1987; ). Mouse H-2k-restricted cytotoxic T cells recognize antigenic determinants in both the HA1 and HA2 subunits of the influenza A/PR/8/34 hemagglutinin. J Exp Med 166, 693–701.[CrossRef]
    [Google Scholar]
  8. Jackson, D. C., Drummer, H. E. & Brown, L. E. ( 1994; ). Conserved determinants for CD4+ T cells within the light chain of the H3 hemagglutinin molecule of influenza virus. Virology 198, 613–623.[CrossRef]
    [Google Scholar]
  9. Katz, J. M., Brown, L. E., Ffrench, R. A. & White, D. O. ( 1985; ). Murine helper T lymphocyte response to influenza virus: recognition of haemagglutinin by subtype-specific and cross-reactive T cell clones. Vaccine 3, 257–262.[CrossRef]
    [Google Scholar]
  10. Knossow, M., Gaudier, M., Douglas, A., Barrere, B., Bizebard, T., Barbey, C., Gigant, B. & Skehel, J. J. ( 2002; ). Mechanism of neutralization of influenza virus infectivity by antibodies. Virology 302, 294–298.[CrossRef]
    [Google Scholar]
  11. Kostolanský, F., Mucha, V., Slováková, R. & Varečková, E. ( 2002; ). Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide. Acta Virol 46, 229–236.
    [Google Scholar]
  12. Kuwano, K., Scott, M., Young, J. F. & Ennis, F. A. ( 1988; ). HA2 subunit of influenza A H1 and H2 subtype induces a protective cross-reactive cytotoxic T lymphocyte response. J Immunol 140, 1264–1268.
    [Google Scholar]
  13. Mbawuike, I. N., Dillion, S. B., Demuth, S. G., Jones, C. S., Cate, T. R. & Couch, R. B. ( 1994; ). Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein. Vaccine 12, 1340–1348.[CrossRef]
    [Google Scholar]
  14. Mitchell, J. A., Green, T. D., Bright, R. A. & Ross, T. M. ( 2003; ). Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins. Vaccine 21, 902–914.[CrossRef]
    [Google Scholar]
  15. Mozdzanowska, K., Feng, J., Eid, M., Kragol, G., Cudic, M., Otvos, L., Jr & Gerhard, W. ( 2003; ). Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine 21, 2616–2626.[CrossRef]
    [Google Scholar]
  16. Nobusawa, E., Aoyama, T., Kato, H., Suzuki, Y., Tateno, Y. & Nakajima, K. ( 1991; ). Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 182, 475–485.[CrossRef]
    [Google Scholar]
  17. Okuno, Y., Isegawa, Y., Sasao, F. & Ueda, S. ( 1993; ). A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol 67, 2552–2558.
    [Google Scholar]
  18. Okuno, Y., Matsumoto, K., Isegawa, Y. & Ueda, S. ( 1994; ). Protection against the mouse-adapted A/FM/1/47 strain of influenza A virus in mice by a monoclonal antibody with cross-neutralizing activity among H1 and H2 strains. J Virol 68, 517–520.
    [Google Scholar]
  19. Russ, G., Poláková, K., Kostolanský, F., Styk, B. & Vančíková, M. ( 1987; ). Monoclonal antibodies to glycopeptides HA1 and HA2 of influenza virus hemagglutinin. Acta Virol 31, 374–386.
    [Google Scholar]
  20. Saikh, K. U., Martin, J. D., Nishikawa, A. H. & Dillon, S. B. ( 1995; ). Influenza A virus-specific H2d restricted cross-reactive cytotoxic T lymphocyte epitope(s) detected in the hemagglutinin HA2 subunit of A/Udorn/72. Virology 214, 445–452.[CrossRef]
    [Google Scholar]
  21. Sánchez-Fauquier, A., Villanueva, N. & Melero, J. A. ( 1987; ). Isolation of cross-reactive, subtype-specific monoclonal antibodies against influenza virus HA1 and HA2 hemagglutinin subunits. Arch Virol 97, 251–265.[CrossRef]
    [Google Scholar]
  22. Sánchez-Fauquier, A., Guillen, M., Martin, J., Kendal, A. P. & Melero, J. A. ( 1991; ). Conservation of epitopes recognized by monoclonal antibodies against the separated subunits of influenza hemagglutinin among type A viruses of the same and different subtypes. Arch Virol 116, 285–292.[CrossRef]
    [Google Scholar]
  23. Skehel, J. J. & Wiley, D. C. ( 2000; ). Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69, 531–569.[CrossRef]
    [Google Scholar]
  24. Smirnov, Y. A., Lipatov, A. S., Gitelman, A. K., Claas, E. C. & Osterhaus, A. D. ( 2000; ). Prevention and treatment of bronchopneumonia in mice caused by mouse-adapted variant of avian H5N2 influenza A virus using monoclonal antibody against conserved epitope in the HA stem. Arch Virol 145, 1733–1741.[CrossRef]
    [Google Scholar]
  25. Spier, R. E. ( 2005; ). On the need for, and the delivery of, cross-protective vaccines. Vaccine 23, 2027–2029.[CrossRef]
    [Google Scholar]
  26. Styk, B., Russ, G. & Poláková, K. ( 1979; ). Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. III. Reactivity with human convalescent sera. Acta Virol 23, 1–8.
    [Google Scholar]
  27. Tamura, M., Webster, R. G. & Ennis, F. A. ( 1994; ). Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses. J Virol 68, 3499–3504.
    [Google Scholar]
  28. Tamura, S., Tanimoto, T. & Kurat, T. ( 2005; ). Mechanism of broad cross-protection provided by influenza virus infection and their application to vaccines. Jpn J Infect Dis 58, 195–207.
    [Google Scholar]
  29. Tkáčová, M., Varečková, E., Baker, I. C., Love, J. M. & Ziegler, T. ( 1997; ). Evaluation of monoclonal antibodies for subtyping of currently circulating human type A influenza viruses. J Clin Microbiol 35, 1196–1198.
    [Google Scholar]
  30. Varečková, E., Cox, N. & Klimov, A. ( 2002; ). Evaluation of the subtype specificity of monoclonal antibodies raised against H1 and H3 subtypes of human influenza A virus hemagglutinins. J Clin Microbiol 40, 2220–2223.[CrossRef]
    [Google Scholar]
  31. Varečková, E., Mucha, V., Wharton, S. A. & Kostolanský, F. ( 2003a; ). Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies. Arch Virol 148, 469–486.[CrossRef]
    [Google Scholar]
  32. Varečková, E., Wharton, S. A., Mucha, V., Gocník, M. & Kostolanský, F. ( 2003b; ). A monoclonal antibody specific to the HA2 glycoprotein of influenza A virus hemagglutinin that inhibits its fusion activity reduces replication of the virus. Acta Virol 47, 229–236.
    [Google Scholar]
  33. Varečková, E., Blaškovičová, H., Gocník, M., Mikas, J., Adamčáková, J., Fislová, T., Kostolanský, F. & Mucha, V. ( 2006; ). Evaluation of clinical specimens for influenza A virus positivity using various diagnostic methods. Acta Virol 50, 181–186.
    [Google Scholar]
  34. Wabuke-Bunoti, M. A., Taku, A., Fan, D. P., Kent, S. & Webster, R. G. ( 1984; ). Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin. J Immunol 133, 2194–2201.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82563-0
Loading
/content/journal/jgv/10.1099/vir.0.82563-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error